A-05 · The Five

Vitamin D3

5
A-05
References 33–39

Vitamin D3

Cholecalciferol · the form made in skin from sunlight · measured in blood as 25-hydroxyvitamin D · often paired with vitamin K2, which has its own entry (J-15)
Primary: control inflammationSecondary: barrierVitamin (secosteroid hormone precursor)Crohn's stronger than UC
vitamin-d3
Sunlight; fatty fish, egg yolkSunlight; fatty fish, egg yolk

Vitamin D3 5,000 IU

Jarrow Formulas · 100 softgels · verified on Fullscript, September 2026
Form
Cholecalciferol 5,000 IU (125 mcg) in extra-virgin olive oil, softgel
Additives
Bovine gelatin softgel, glycerin, water, clean
Why this one
Standalone D3 in an oil base, better absorbed than dry tablets when fat absorption is impaired, and no combination ingredients. Get a 25(OH)D test first; this is the one entry where the right amount is knowable.
SKU
JAR-D5000

What it is

Vitamin D is less a vitamin than the precursor to a hormone, and its receptor is found on nearly every immune cell in the gut. Deficiency and insufficiency are extremely common in IBD, poor absorption, less sun, steroid courses, and inflammation itself all push levels down, and low levels track with higher disease activity, more hospitalizations and more surgery in observational studies. That much is settled. Whether giving vitamin D changes the course of the disease is the live question, and the randomized trials, pooled, lean toward yes in Crohn's disease.

How it works

The active hormone binds the vitamin D receptor on T cells and shifts the immune response away from the inflammatory Th1 and Th17 programs and toward regulatory T cells and IL-10, the immune system's brakes. In the epithelium, VDR signaling maintains tight-junction proteins (claudins, ZO-1) and induces the antimicrobial peptides cathelicidin and β-defensin, so the barrier is both tighter and better defended. It is essential for calcium absorption and bone, and bone loss is one of the most common complications of IBD, made worse by every steroid course. Magnesium is required for the enzymes that activate it, which is why the two are often considered together.

Cholecalciferol (vitamin D3), C27H44O, 384.6 g/mol. A secosteroid: a cholesterol skeleton with one ring opened by ultraviolet light. Real structure; PubChem CID 5280795.
Category
Fat-soluble vitamin
Phenotype
Crohn's disease in remission (strongest pooled effect on relapse); UC data limited
Other IBD
Indeterminate colitis: read both. Microscopic colitis: no trials; relevant for bone protection during budesonide, a corticosteroid, in a population that skews older.
Whole-food source
Sunlight on skin; fatty fish, cod-liver oil, egg yolk; fortified foods. Diet alone rarely corrects a deficiency
Cross-references
J-15 vitamin K (calcium partner) · J-05 magnesium (activation cofactor) · J-07 calcium
Evidence4

Randomized trials in Crohn's show fewer relapses when pooled (three meta-analyses agree), but individual trials are small, the landmark trial just missed significance (p = 0.06), and a high-dose post-operative trial was negative. UC data are sparse.

Andrew's score5

Andrew's judgment, 1–5, labeled as opinion.

The evidence

Jørgensen et al., 2010Aliment Pharmacol Ther · RCT, 108 randomized / 94 analyzed

Crohn's disease in remission. Vitamin D3 1,200 IU/day (with 1,200 mg calcium) or placebo (calcium alone) for 12 months. Serum 25(OH)D rose from 69 to 96 nmol/L by 3 months. Relapse 13% (6/46) on vitamin D vs 29% (14/48) on placebo, p = 0.06, a halving of relapse that narrowly missed statistical significance in a trial that was too small. No hypercalcemia.

Systematic review with meta-analysis, 2024Inflamm Bowel Dis · RCTs, 458 patients

Pooled risk of clinical relapse 0.64 (95% CI 0.46–0.89) with vitamin D supplementation across IBD; in Crohn's patients in clinical remission specifically, risk ratio 0.47 (0.27–0.82) with no heterogeneity. Only two UC studies (67 patients) were available, the UC signal is a gap, not a negative.

Two earlier meta-analyses, 2018 and 2020Medicine; and a 2020 systematic review of 5 studies (n = 253)

Both reached the same direction: lower relapse with supplementation (the 2020 analysis reported an odds ratio of 0.33 with no heterogeneity), and no clear advantage of high-dose over low-dose regimens.

de Bruyn et al., 2021Clin Gastroenterol Hepatol · Dutch-Belgian RCT, post-operative Crohn's

High-dose vitamin D (25,000 IU weekly) did not prevent post-operative recurrence of Crohn's disease. An important negative result: the benefit seen in medically maintained remission did not carry over to the post-surgical setting at this dose.

Dose as studied

Scroll sideways to see every column →

StudyPopulationDoseDuration
Jørgensen 2010Crohn's, remission1,200 IU/day + 1,200 mg calcium12 months
de Bruyn 2021Crohn's, post-op25,000 IU weekly (negative)—
Trials pooled in meta-analysesIBDRoughly 1,000–10,000 IU/day3–12 months

Reported as used in the trials named. Not a recommendation. Vitamin D dosing is normally guided by a blood test.

What to expect

Blood levels change over about 3 months; the relapse endpoints in the trials were measured at 12. You won't feel vitamin D working. The way to know is a 25(OH)D test, which is cheap, standard, and the single most useful lab in this entire guide, because vitamin D is the one entry where the right amount is knowable for you personally.

Form, timing and bioavailability

D3 (cholecalciferol) raises blood levels more effectively than D2 (ergocalciferol), the form still in some prescriptions. It is fat-soluble: take it with a meal containing fat. In Crohn's with ileal disease, bile-acid problems or steatorrhea, absorption of fat-soluble vitamins can be poor, and oil-based softgels or emulsified liquid drops are generally absorbed better than dry tablets. Because the correct amount depends entirely on your current level, this is the entry where "dose as studied" is least useful and a lab result is most useful.

Who should be careful

Hypercalcemia or hyperparathyroidism; a history of calcium kidney stones; sarcoidosis and other granulomatous diseases (which activate vitamin D outside the kidney and can push calcium up). Toxicity is real but is associated with sustained intakes far above anything in the trials above, the concern is prolonged very-high dosing without testing, not a normal supplement.

Interactions with IBD medications

Corticosteroids (prednisone, budesonide) impair vitamin D metabolism and accelerate bone loss, the interaction runs the other way: steroids raise the need. Cholestyramine (sometimes used for bile-acid diarrhea) blocks absorption; separate by several hours. Thiazide diuretics plus vitamin D can raise calcium. No interactions with mesalamine, thiopurines, methotrexate or biologics.

Andrew's notes

Many practitioners I respect aim for a blood level at the upper end of the normal range, and some use higher doses than the label to get there, under supervision and with repeat testing; the amount a given person needs depends on absorption, and a resection or active small-bowel disease changes it. Vitamin D is fat-soluble and excess is real: I have not personally seen toxicity, which is not evidence that it cannot happen. The rule I follow with my own level is the boring one: test, dose with your team, and retest.

References

  1. Jørgensen SP, Agnholt J, Glerup H, et al. Clinical trial: vitamin D3 treatment in Crohn's disease – a randomized double-blind placebo-controlled study. Aliment Pharmacol Ther 2010;32(3):377–383.
  2. Effectiveness of vitamin D supplementation on disease course in inflammatory bowel disease patients: systematic review with meta-analysis. Inflamm Bowel Dis 2024;30(2):281–291. (RR 0.64; Crohn's in remission RR 0.47.)
  3. de Bruyn JR, Bossuyt P, Ferrante M, et al. High-dose vitamin D does not prevent postoperative recurrence of Crohn's disease in a randomized placebo-controlled trial. Clin Gastroenterol Hepatol 2021;19(8):1573–1582.e5.
  4. Li J, Chen N, Wang D, Zhang J, Gong X. Efficacy of vitamin D in treatment of inflammatory bowel disease: a meta-analysis. Medicine (Baltimore) 2018;97(46):e12662. (Vitamin D reduced relapse rate; no difference between high and low doses on relapse.)
  5. Guzman-Prado Y, et al. Vitamin D therapy in adults with inflammatory bowel disease: a systematic review and meta-analysis. Inflamm Bowel Dis 2020. (Cited as reference 26 of the 2024 IBD meta-analysis; did not assess relapse.)
  6. Ananthakrishnan AN, Khalili H, Higuchi LM, et al. Higher predicted vitamin D status is associated with reduced risk of Crohn's disease. Gastroenterology 2012;142(3):482–489.
  7. Efficacy and safety of vitamin D adjuvant therapy for ulcerative colitis: a meta-analysis. 2022. PMC9328974. (Vitamin D plus mesalazine vs mesalazine: clinical efficacy OR 4.07, lower Mayo scores; mostly Chinese trials.)

READ & SHOP

Explore related supplements

Browse all 100 →

Vitamins & Minerals

Magnesium

Magnesium glycinate, the form least likely to loosen stool, 120 mg of elemental magnesium per capsule with nothing else but the capsule and a trace of ascorbyl…

Evidence 3/5Andrew 4/5

Options to explore with your care team. These are not a recommendation to take them together. Andrew earns a commission on Fullscript purchases. US shipping only.